DIPSS-plus improves outcome prediction after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis

被引：0
|
作者：
Ditschkowski, M. [1 ]
Elmaagacli, A. H. [1 ]
Steckel, N. K. [1 ]
Gromke, T. [1 ]
Trenschel, R. [1 ]
Koldehoff, M. [1 ]
Beeen, D. W. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [11] Safety and outcome of allogeneic stem cell transplantation in myelofibrosis
    Markiewicz, Miroslaw
    Mietla, Monika Dzierzak
    Wieczorkiewicz, Agata
    Mizia, Sylwia
    Helbig, Grzegorz
    Kopera, Malgorzata
    Bialas, Krzysztof
    Rybicka, Malwina
    Matyja, Mariusz
    Koclega, Anna
    Sedlak, Lech
    Oleksy, Tomasz
    Raman, Sundar
    Kyrcz-Krzemien, Slawomira
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (03) : 222 - 228
  • [12] Myeloablative allogeneic haematopoietic stem cell transplantation for myelofibrosis with myeloid metaplasia
    Ditschkowski, M.
    Keller, M. T.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Koldehoff, M.
    Schulte, C.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S9 - S10
  • [13] Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis
    S Lissandre
    J-O Bay
    J-Y Cahn
    R Porcher
    V Cacheux
    A Cabrespine
    J Cornillon
    B Cassinat
    R Peffault de Latour
    G Socie
    M Robin
    Bone Marrow Transplantation, 2011, 46 : 557 - 561
  • [14] Retrospective study of allogeneic haematopoietic stem-cell transplantation for myelofibrosis
    Lissandre, S.
    Bay, J-O
    Cahn, J-Y
    Porcher, R.
    Cacheux, V.
    Cabrespine, A.
    Cornillon, J.
    Cassinat, B.
    de Latour, R. Peffault
    Socie, G.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 (04) : 557 - 561
  • [15] Decreased relapse risk after allogeneic hematopoietic stem cell transplantation (HSCT) in myelofibrosis with splenomegaly
    Ditschkowski, M.
    Steckel, N. K.
    Trenschel, R.
    Gromke, T.
    Beelen, D. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 229 - 230
  • [16] Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, M.
    Elmaagacli, A. H.
    Trenschel, R.
    Steckel, N. K.
    Gromke, T.
    Koldehoff, M.
    Beelen, D. W.
    ONKOLOGIE, 2011, 34 : 206 - 206
  • [17] Quantitative analysis of EBV DNA in children after allogeneic haematopoietic stem cell transplantation (HSCT).
    Friman, Vanda
    Lindh, Magnus
    Mellgren, Karin
    Kullberg-Lindh, Carola
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 83 - 83
  • [18] Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
    Atagunduz, Isik Kaygusuz
    Christopeit, Maximilian
    Ayuk, Francis
    Zeck, Gaby
    Wolschke, Christine
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (12) : 2279 - 2284
  • [19] Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Smallbone, Portia
    Louw, Alison
    Purtill, Duncan
    PATHOLOGY, 2024, 56 (01) : 24 - 32
  • [20] Potential Role of Immunoregulatory Mirna in Haematopoietic Allogeneic Stem Cell Transplantation (HSCT)
    Jordan, K.
    Heegaard, N.
    Carlsen, A.
    Sengelov, H.
    Muller, K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 77 (04) : 287 - 287
12345